Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers February 21, 2019
Pharmacy Choice - Pharmaceutical News - Global Parkinson's Disease Drugs Market 2018-2023: Recent Drug Approvals are Driving Growth - - February 21, 2019

Pharmacy News Article

 9/19/18 - Global Parkinson's Disease Drugs Market 2018-2023: Recent Drug Approvals are Driving Growth -

DUBLIN(BUSINESS WIRE) The "Global Parkinson's Disease Drugs Market - Segmented by Mechanism of Action and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to's offering.

The Parkinson's disease drugs market is expected to witness a CAGR of 6.2% during the forecast period, 2018-2023. The global Parkinson's disease drug market has witnessed a remarkable growth in the recent years, due to a large patient pool and increased diagnosis rates.

Recent Drug Approvals

Researchers are working to develop new and improved therapies for people with Parkinson's disease (PD). There have been many drugs that have been approved to treat Parkinson disease. In January 2015, the US FDA approved an extended release formulation of levodopa/carbidopa.
Recently in January 2018, Adamas Pharmaceuticals Inc. has launched Gocovri (amantadine extended-release capsules) for the treatment of dyskinesia in people with Parkinson's, who are taking levodopa. This is the first drug indicated specifically for dyskinesia, which is developed with the long-term usage of levodopa.
These newly-approved drugs, with different formulations, are addressing different unmet needs and are expected to drive the Parkinson disease drug market.

The other factors, which are also driving the market, include increasing demand due to the higher prevalence of the disease, new entrants expected to balance generic intrusion, and increasing use of the MAO-B inhibitor.

Key Highlights
  • Generic Competition to Key Therapies - Restraining the Market
  • Europe Holds the Largest Share of the Market

Major Market Developments

  • Pfizer, the world's third-largest drug maker, announced that it is ending research to discover new medications for Alzheimer's and Parkinson's diseases, due to the high cost involved.
  • Adamas Pharmaceuticals Inc. launched Gocovri (amantadine extended-release capsules) for the treatment of dyskinesia.
Companies Featured
  • Merck & Co. Inc.
  • Impax Laboratories Inc.
  • Abbvie Inc.
  • Mylan N.V.
  • Boehringer Ingelheim
  • GlaxoSmithKline plc
  • Somerset Pharmaceuticals Inc.
  • Teva Pharmaceuticals
  • Pfizer
  • Novartis AG
  • Johnson & Johnson (Janssen)
  • Allergan plc

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. The Future of the Market

For more information about this report visit

Laura Wood, Senior Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics: Central Nervous System Drugs

Source: Research and Markets

Copyright Business Wire 2018

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Feb 22: Medical Marijuana: The Basic and Clinical Pharmacology, Not The Politics
Feb 24: A Primer to Paleo
Feb 25: Obesity Management: Overview of Pharmacotherapy
Feb 26: Mobile Applications for Pharmacists: Tools That Help Pharmacies be Successful
Feb 28: Beyond the Biome- Managing Gut Health Through Lifestyle Medicine
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement